Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$11.90
-0.44-3.57%
At close: Dec 16, 4:00 PM EST
$11.85
-0.05-0.42%
After Hours: 4:43 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Arvinas (ARVN) stock?
You can purchase shares of Arvinas (NASDAQ:ARVN) through any online brokerage.
Who are Arvinas (ARVN) competitors?
Other companies in Arvinas’s space includes: Theravance Biopharma Inc (NASDAQ:TBPH), Zevra Therapeutics Inc (NASDAQ:ZVRA), GH Research PLC (NASDAQ:GHRS), SNDL Inc (NASDAQ:SNDL) and Xeris Biopharma Holdings Inc (NASDAQ:XERS).
What is the forecast, or price target, for Arvinas (ARVN) stock?
Arvinas has a consensus price target of $23.37.
What is the current price for Arvinas (ARVN)?
The stock price for Arvinas (NASDAQ: ARVN) is $11.85 last updated December 16, 2025 at 4:43 PM EST.
Does Arvinas (ARVN) pay a dividend?
There are no upcoming dividends for Arvinas.
When is Arvinas (NASDAQ:ARVN) reporting earnings?
Arvinas does not have any upcoming earnings scheduled.
Is Arvinas (ARVN) going to split?
There is no upcoming split for Arvinas.
What sector and industry does Arvinas (ARVN) operate in?
Arvinas is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
